PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.37%
Revenue growth under 50% of ADI's 6.76%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-7.67%
Negative gross profit growth while ADI is at 5.78%. Joel Greenblatt would examine cost competitiveness or demand decline.
-217.14%
Negative EBIT growth while ADI is at 59.70%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-217.14%
Negative operating income growth while ADI is at 59.70%. Joel Greenblatt would press for urgent turnaround measures.
-190.74%
Negative net income growth while ADI stands at 78.38%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-160.00%
Negative EPS growth while ADI is at 200.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-160.00%
Negative diluted EPS growth while ADI is at 200.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.49%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.49%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
402.45%
Dividend growth of 402.45% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-59.18%
Negative OCF growth while ADI is at 411.63%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
0.93%
FCF growth under 50% of ADI's 178.64%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
30.70%
10Y revenue/share CAGR under 50% of ADI's 98.76%. Michael Burry would suspect a lasting competitive disadvantage.
30.70%
5Y revenue/share CAGR under 50% of ADI's 98.76%. Michael Burry would suspect a significant competitive gap or product weakness.
8.56%
3Y revenue/share CAGR under 50% of ADI's 58.94%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1331.05%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1331.05%
Negative 5Y net income/share CAGR while ADI is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-271.58%
Negative 3Y CAGR while ADI is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
857.05%
Dividend/share CAGR of 857.05% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
857.05%
Dividend/share CAGR of 857.05% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
786.16%
3Y dividend/share CAGR of 786.16% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.53%
AR growth well above ADI's 2.68%. Michael Burry fears inflated revenue or higher default risk in the near future.
-4.17%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.07%
Negative asset growth while ADI invests at 1.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.85%
We have a declining book value while ADI shows 29.66%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
19.44%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
16.77%
SG&A growth well above ADI's 1.34%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.